J.C. Lopez

J.C. Lopez is a Principal at New Enterprise Associates (NEA) since November 2020, bringing extensive experience in business development and strategy within the biopharma sector. Previous roles include serving as the Global S&E Lead for Neuroscience, Ophthalmology, and Rare Diseases Partnering at Genentech, where leadership encompassed global search and evaluation efforts, and positions at F1 Oncology, Genentech, and Militia Hill Ventures focused on market analysis and strategy development. J.C. co-founded Angiio LLC to create a novel sutureless device for vascular procedures, while earlier contributions included coordinating innovative medical solutions at Penn Medicine and assessing commercial potential for technologies at the University of Pennsylvania. Academic credentials include an MD from the University of Pennsylvania School of Medicine, an MBA in Healthcare Management from The Wharton School, and a BS in Biology from Stanford University.